Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kangxinfang Formula (康心方配方颗粒) is a traditional Chinese medicine (TCM) formula prepared as granules for clinical use. It belongs to the category of "中药配方颗粒" (Chinese herbal formula granules), which are standardized single-herb or multi-herb TCM preparations processed into granule form for ease of use and consistent dosing. These products are manufactured according to national or provincial standards in China, with quality control measures including fingerprint chromatograms and content determination of active ingredients. The specific composition and mechanism of action for Kangxinfang Formula are not detailed in the available sources, but such formulas typically aim to support cardiovascular health based on TCM principles. The product is used in medical institutions approved or registered to provide TCM services[2][5]. Its development and manufacturing follow strict regulatory guidelines set by the National Medical Products Administration (NMPA)[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kangxinfang Formula.